Cargando…
Onivyde for the therapy of multiple solid tumors
Drug delivery system based on nanobiotechnology can improve the pharmacokinetics and therapeutic index of chemotherapeutic agents, which has revolutionized tumor therapy. Onivyde, also known as MM-398 or PEP02, is a nanoliposomal formulation of irinotecan which has demonstrated encouraging anticance...
Autor principal: | Zhang, Haijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881920/ https://www.ncbi.nlm.nih.gov/pubmed/27284250 http://dx.doi.org/10.2147/OTT.S105587 |
Ejemplares similares
-
Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs
por: Milano, Gérard, et al.
Publicado: (2022) -
Fluorescence Lifetime Nanoscopy of Liposomal Irinotecan
Onivyde: From Manufacturing to Intracellular Processing
por: Bernardi, Mario, et al.
Publicado: (2023) -
Apatinib for molecular targeted therapy in tumor
por: Zhang, Haijun
Publicado: (2015) -
Current Progress in CAR-T Cell Therapy for Solid Tumors
por: Ma, Shuo, et al.
Publicado: (2019) -
Potential of epigenetic therapies in the management of solid tumors
por: Valdespino, Victor, et al.
Publicado: (2015)